Beam Therapeutics
BEAM
BEAM
224 hedge funds and large institutions have $2.6B invested in Beam Therapeutics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 74 increasing their positions, 65 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% more funds holding
Funds holding: 205 → 224 (+19)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.26% less ownership
Funds ownership: 77.81% → 77.55% (-0.26%)
Holders
224
Holding in Top 10
3
Calls
$53.9M
Puts
$15.5M
Top Buyers
| 1 | +$44.2M | |
| 2 | +$17.8M | |
| 3 | +$12.7M | |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$11M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$10.4M |
Top Sellers
| 1 | -$52.1M | |
| 2 | -$36.9M | |
| 3 | -$14.3M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$11.9M |
| 5 |
Millennium Management
New York
|
-$11.1M |